Stock comparison
Genpact LTD is 1.9x more valuable than Astrana Health, Inc. by market capitalization ($4.98 B vs $2.56 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
G is larger
Genpact LTD is 1.9x more valuable than Astrana Health, Inc. by market capitalization ($4.98 B vs $2.56 B).
Market value leader
G
Genpact LTD is 1.9x more valuable than Astrana Health, Inc. by market capitalization ($4.98 B vs $2.56 B).
Revenue leader
G
ASTH: $3.18B vs G: $5.08B.
Profit leader
G
ASTH: $24.00M vs G: $552.49M.
Margin leader
G
ASTH: 0.8% vs G: 10.9% net margin.
| Metric | ASTH | G |
|---|---|---|
| Market cap | $2.56 B | $4.98 B |
| US-listed rank | #1959 | #1421 |
| Revenue (latest FY) | $3.18B | $5.08B |
| Net income (latest FY) | $24.00M | $552.49M |
| Net margin | 0.8% | 10.9% |
| P/E (trailing FY) | 106.5x | 9.0x |
| SEC filings | 1,003 | 1,502 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
Genpact LTD is 1.9x more valuable than Astrana Health, Inc. by market capitalization ($4.98 B vs $2.56 B).
In their latest fiscal years, Astrana Health, Inc. reported $3.18B in revenue while Genpact LTD reported $5.08B.
Full pages: Astrana Health, Inc. and Genpact LTD, or browse the full rankings.